blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3394262

EP3394262 - ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  26.07.2024
Database last updated on 13.09.2024
FormerGrant of patent is intended
Status updated on  25.04.2024
FormerExamination is in progress
Status updated on  18.12.2020
FormerRequest for examination was made
Status updated on  28.09.2018
FormerThe international publication has been made
Status updated on  05.07.2017
Most recent event   Tooltip26.07.2024(Expected) grantpublished on 28.08.2024  [2024/35]
Applicant(s)For all designated states
Oregon State University
220 Nash Hall
Corvallis OR 97331-3804 / US
For all designated states
Board of Regents, The University of Texas System
210 West 7th Street
Austin, TX 78701 / US
[2018/44]
Inventor(s)01 / GREENBERG, David
408 Pecan Hollow Drive
Coppell, TX 75019 / US
02 / GELLER, Bruce L.
6994 N.W. Concord Drive
Corvallis, OR 97330 / US
 [2018/44]
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[2024/35]
Former [2018/44]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Application number, filing date16880107.422.12.2016
[2018/44]
WO2016US68376
Priority number, dateUS201562387178P23.12.2015         Original published format: US 201562387178 P
[2018/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017112888
Date:29.06.2017
Language:EN
[2017/26]
Type: A1 Application with search report 
No.:EP3394262
Date:31.10.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 29.06.2017 takes the place of the publication of the European patent application.
[2018/44]
Type: B1 Patent specification 
No.:EP3394262
Date:28.08.2024
Language:EN
[2024/35]
Search report(s)International search report - published on:US29.06.2017
(Supplementary) European search report - dispatched on:EP25.11.2019
ClassificationIPC:C12N15/113, A61P31/04, A61K31/712
[2019/39]
CPC:
C12N15/113 (EP,US); A61K31/7115 (EP,US); A61K31/712 (EP,US);
A61K47/42 (US); A61K47/66 (US); A61P31/04 (EP);
A61P43/00 (EP); C12N2310/11 (EP,US); C12N2310/3233 (EP,US);
C12N2310/3513 (EP,US); Y02A50/30 (EP) (-)
Former IPC [2018/44]C12N15/113
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/44]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:ANTIBAKTERIELLE ANTISENSE-VERBINDUNGEN UND VERFAHREN[2018/44]
English:ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS[2018/44]
French:COMPOSÉS ANTIBACTÉRIENS ANTISENS ET PROCÉDÉS ASSOCIÉS[2018/44]
Entry into regional phase23.07.2018National basic fee paid 
23.07.2018Search fee paid 
23.07.2018Designation fee(s) paid 
23.07.2018Examination fee paid 
Examination procedure23.07.2018Examination requested  [2018/44]
23.07.2018Date on which the examining division has become responsible
04.06.2020Amendment by applicant (claims and/or description)
18.12.2020Despatch of a communication from the examining division (Time limit: M04)
26.03.2021Reply to a communication from the examining division
26.04.2024Communication of intention to grant the patent
22.07.2024Fee for grant paid
22.07.2024Fee for publishing/printing paid
22.07.2024Receipt of the translation of the claim(s)
Fees paidRenewal fee
23.07.2018Renewal fee patent year 03
01.06.2020Renewal fee patent year 04
31.12.2020Renewal fee patent year 05
31.12.2021Renewal fee patent year 06
30.12.2022Renewal fee patent year 07
27.12.2023Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.12.201904   M06   Fee paid on   01.06.2020
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2007009094  (AVI BIOPHARMA INC [US], et al);
 [XI]WO2015179249  (GELLER BRUCE L [US], et al);
 [XI]US2015361425  (GELLER BRUCE L [US], et al);
International search[A]US2013288369  (IVERSEN PATRICK L [US]);
 [A]US2015141321  (KOLE RYSZARD [US], et al);
 [X]US2015361425  (GELLER BRUCE L [US], et al)
by applicantUS5034506
 US5142047
 US5166315
 WO9301286
 US5185444
 US5217866
 US5506337
 US5521063
 US5698685
 US6245747
 WO2004097017
 US6965025
 US6969400
 WO2007009094
 WO2009005793
 WO2009064471
 US2010016215
 US8076476
 WO2012043730
 US8299206
 WO2012150960
 WO2015179249
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.